Article
Fluorescence resonance energy transfer usage to track the sequence promoter changes in CGB5 gene in ovarian cancer patients.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie - 1 Jun 2017
Andrusiewicz Mirosław, Skibińska Izabela, Gąsiorowska Emilia, Białas Piotr, Kotwicka Małgorzata
Abstract excerpt
PURPOSE: The survival rates for ovarian cancer patients remain very low, often as a result of late diagnosis due to the asymptomatic course of the early stage disease. Based on the important biological contribution of human chorionic gonadotropin to various key processes including; cell cycle control, DNA repair, cellular differentiation and developmental processes, we hypothesized that genetic polymorphisms in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
